Skip to main content

Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction

Vancouver, Canada, July 17, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogenderived treatments for Alcohol Use Disorder (AUD), addiction, and weight management, today noted the significant regulatory and inter-agency developments this week supporting the development of innovative treatments for serious neuropsychiatric and addiction disorders. Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine, stated: “At a time when patients in the veterans community and the general population have too few treatment options for intractable neuropsychiatric and addiction disorders, we are grateful that Secretary Kennedy is looking to transform treatment opportunities through the expansion of new therapeutic approaches.” This week’s developments include...

Continue reading

42/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities

Schindellegi, Switzerland – 17 July 2026 Trifork Group AGCompany announcement no. 42/2026 Reporting of transactions made by persons discharging managerial responsibilities Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Trifork or persons closely associated with them.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Anja Monrad2. Reason for the notificationa) Position/status Chairperson of the Board of Directorsb) Initial notification/Amendment Initial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction...

Continue reading

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

Three-year data from phase 2 trial will provide additional insights into potentially enhanced treatment effects and durability of the EVX-01-induced immune response Data will also offer insight into the vaccine’s effect also as stand-alone treatment of patients with advanced melanoma Unprecedented two-year data from the trial presented last year showed high response rates and an impressive durability of responsesCOPENHAGEN, Denmark, July 17, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will present three-year clinical efficacy data from its phase 2 trial with personalized cancer vaccine candidate EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2026 to be held in Madrid, Spain, from October 23-27,...

Continue reading

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts

Data from the expanded cohorts reinforce the positive BCVA, OCT, pharmacokinetic and time-to-retreatment findings observed in the original cohorts Enrollment in the Phase 1b/2 multiple-ascending dose trial of TH103 continues, with preliminary data on track for 1H 2027 BERKELEY HEIGHTS, N.J., July 17, 2026 (GLOBE NEWSWIRE) — Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced positive additional data from its Phase 1a single ascending dose (SAD) trial of TH103 in neovascular age-related macular degeneration (AMD). Data from the expanded cohorts build on previously reported positive findings from the trial, with additional patients showing improvements in vision and retinal...

Continue reading

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

BrewDog and Tilray are keeping football’s biggest celebration alive by unlocking the £1 million bar tab at participating pubs1 beginning July 20 because great football deserves celebrating, no matter who lifts the trophyLONDON and ELLON, Scotland, July 17, 2026 (GLOBE NEWSWIRE) — Leading UK craft beer brand and Scottish brewer BrewDog, owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today announced that this celebration is for the fans. BrewDog and Tilray Brands will continue bringing football supporters together with watch parties throughout the tournament and will keep the celebration going after the final whistle by kicking off the £1 million bar tab at participating BrewDog pubs beginning July 20, 2026. Running through September 30, 2026, the bar tab gives fans across England, Scotland and Ireland more reasons to come...

Continue reading

MoonFox Alternative Data Expands Offline Foot Traffic Coverage to Leading China and Global Stocks

SHENZHEN, China, July 17, 2026 (GLOBE NEWSWIRE) — MoonFox Data, China’s leading alternative data provider, is proud to announce a major expansion of its offline (foot traffic) data coverage, now tracking real-world consumer flows for a new cohort of high-impact listed companies across A-shares, Hong Kong, and US markets. This enhancement further cements MoonFox’s position as the definitive source for actionable China data, empowering global institutional investors with unparalleled visibility into the operational pulse of the world’s fastest-growing consumer economy. Key Highlights:Expanded Universe: MoonFox’s offline dataset now covers 300+ additional stocks, including top A-share names, Hong Kong blue chips, and select US-listed Chinese and global consumer brands. Sector Breadth: Newly added coverage spans core consumer-facing...

Continue reading

Click Holdings Limited (CLIK) Surpasses 6 Million Senior Care Hours; Unveils Global ESG Framework to Power International and Mainland China Expansion

Hong Kong, July 17, 2026 (GLOBE NEWSWIRE) — Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leader in human resources (“HR”) and senior care solutions in Hong Kong, today announced a historic milestone in its corporate social responsibility framework, having officially delivered more than 6,000,000 cumulative service hours to seniors. This milestone underscores Click’s unique capability to drive high-margin commercial growth while solving critical global demographic challenges. As societies worldwide face unprecedented aging demographics and severe healthcare labor shortages, Click’s proprietary human capital solutions have emerged as a highly scalable blueprint. By deploying specialized workforce management technologies to optimize healthcare...

Continue reading

CrossAmerica Partners to Announce Second Quarter 2026 Earnings Results on August 5

Allentown, PA, July 17, 2026 (GLOBE NEWSWIRE) — CrossAmerica Partners to Announce Second Quarter 2026 Earnings Results on August 5 ALLENTOWN, PA, July 17, 2026 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its second quarter 2026 results after the market closes on Wednesday, August 5, 2026. In conjunction with the news release, management will host a conference call on Thursday, August 6, at 9:00 a.m. Eastern Time. The conference call numbers are 800-717-1738 or 646-307-1865 and the passcode for both is 292954. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website...

Continue reading

Costamare Bulkers Holdings Limited Announces 2026 Annual Meeting of Shareholders

MONACO, July 17, 2026 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (“Costamare Bulkers” or the “Company”) (NYSE:CMDB), announced today that its Board of Directors has called an annual meeting of the shareholders to be held virtually on Thursday, October 8, 2026. Shareholders of record of the Company’s common stock at the close of business on Thursday, August 13, 2026 will be entitled to receive notice of, and to vote at, the annual meeting and at any adjournments or postponements thereof. The notice of the annual meeting and the Company’s proxy statement will be sent to shareholders of record on or around Friday, August 14, 2026. About Costamare Bulkers Holdings Limited Costamare Bulkers Holdings Limited is an international owner and operator of dry bulk vessels. Costamare Bulkers’ owned dry bulk fleet consists of 30 vessels...

Continue reading

Essent Group Ltd. Schedules Second Quarter Earnings Conference Call for August 7, 2026

HAMILTON, Bermuda, July 17, 2026 (GLOBE NEWSWIRE) — Essent Group Ltd. (NYSE: ESNT) today announced that it will hold a conference call on Friday, August 7, 2026, at 10:00 a.m. Eastern Time to discuss the Company’s second quarter 2026 results, which will be announced prior to the market open on the same day. The conference call will be broadcast live over the Internet at http://ir.essentgroup.com/events-and-presentations/events/default.aspx. The call may also be accessed by dialing 888-330-2384 inside the U.S., or 240-789-2701 for international callers, using passcode 9824537 or by referencing Essent. A replay of the webcast will be available on the Essent website approximately two hours after the live broadcast ends for a period of one year. A replay of the conference call will be available approximately two hours after the call...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.